«

»

Sep 25

New, longer-term data on the Watchman left atrial appendage occluder from Boston Scientific studied in the PREVAIL trial suggests an increased risk of ischemic stroke in atrial fibrillation

New, longer-term data on the Watchman left atrial appendage occluder from Boston Scientific studied in the PREVAIL trial suggests an increased risk of ischemic stroke in atrial fibrillation patients treated with this novel device. The findings were published in the Journal of the American College of Cardiology.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>